This study sought to assess the 2-year outcomes of the population included in the EXAMINATION ( Everolimus-Eluting Stents Versus Bare-Metal Stents in ST-Segment Elevation Myocardial Infarction ) trial beyond the 1-year prescription period of dual antiplatelet therapy .